SCHEMBL9186731

SCHEMBL9186731

CSc1ccc(Sc2ccccc2[N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE7A Q13946 6/20 0.56
▸ SMN1; SMN2 Q16637 2/20 0.56
▸ SLC6A2 P23975 2/20 0.50
▸ SLC6A4 P31645 2/20 0.50
▸ SLC6A3 Q01959 2/20 0.50
▸ PDE7B Q9NP56 2/20 0.50
▸ MAPT P10636 6/20 0.49
▸ ALDH1A1 P00352 4/20 0.45
▸ HPGD P15428 2/20 0.45
▸ KDM4E B2RXH2 1/20 0.45
▸ HSD17B10 Q99714 1/20 0.44
▸ MEN1 O00255 4/20 0.44
▸ KMT2A Q03164 4/20 0.44
▸ GAA P10253 1/20 0.44
▸ TDP1 Q9NUW8 1/20 0.44
▸ HTT P42858 1/20 0.43
▸ NPSR1 Q6W5P4 1/20 0.43
▸ GSTP1 P09211 1/20 0.43
▸ GSTM2 P28161 1/20 0.43
▸ POLB P06746 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8881808 0.86 MAPT (0.58) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL1713219 0.85 PDE7A (0.65) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL30338244 0.85 PDE7A (0.65) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL3384869 0.83 PDE7A (0.58) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL7665295 0.83 PDE7A (0.67) PDE7ASMN1; SMN2PDE7BMEN1KMT2A
SCHEMBL2614719 0.83 PDE7A (0.59) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL11760310 0.83 PDE7A (0.56) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL10923003 0.83 PDE7A (0.65) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3
SCHEMBL25250134 0.82 PDE7A (0.66) PDE7ASMN1; SMN2PDE7BMAPTALDH1A1
SCHEMBL12925885 0.82 PDE7A (0.51) PDE7ASMN1; SMN2SLC6A2SLC6A4SLC6A3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0451675-B1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON SPA (IT) 1995-11-02 — — EP disclosed
US-5191078-A Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON GROUP S.P.A. (IT) 1993-03-02 — — US disclosed
US-5109134-A PROCESS FOR THE DIRECT AND REGIOSELECTIVE FUNCTIONALIZATION IN POSITION 2 OF PHENOTHIAZINE ZAMBON GROUP S.P.A. (IT) 1992-04-28 — — US disclosed
US-5089613-A Sulfonation of N-acylphenothiazine with sulfuric acid, oleum or chlorosulfonic acid then reduciton to mercaptan and S-alkylation ZAMBON GROUP S.P.A. (IT) 1992-02-18 — — US disclosed
EP-0451675-A1 Process for the direct and regioselective functionalization in position 2 of phenothiazine ZAMBON GROUP S.p.A. (IT) 1991-10-16 — — EP disclosed
EP-0433841-A2 Process for the direct and regioselective functionalization in position 2 of phenotiazine ZAMBON GROUP S.p.A. (IT) 1991-06-26 — — EP disclosed
Send feedback